Skip to content
Home
Our Science
Pipeline & Assets
Team & Investors
Careers
News & Resources
Connect
News
& Resources
Featured Stories
GlobeNewswire
Siren Biotechnology Awarded $8M in Non-Dilutive Grant Funding from CIRM to Support Clinical Development of SRN-101 in High-Grade Glioma
Read More
Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage
Read More
GlobeNewswire
Siren Biotechnology Publishes Foundational AAV Immuno-Gene Therapy Data and Announces Presentations at ASGCT 2026
Read More
News
Patient Resources
Videos
Publications & Presentations
All
Media Coverage
Press Releases
Media Coverage
|
Posted on 4.27.24
How Viral Gene Therapy will Revolutionize Cancer Treatment
Read More
Media Coverage
|
Posted on 4.3.24
Biopharma’s AI Revolution | The Future of Medicine
Read More
Media Coverage
|
Posted on 3.20.24
Venture Europe Podcast – Tackling cancer with gene therapy
Read More
Media Coverage
|
Posted on 3.1.24
Webinar – Undoing the Dogma: A Changing Ethos in AAV Gene Therapy Manufacturing
Read More
Media Coverage
|
Posted on 2.6.24
Exploring the frontiers of gene therapy and AAVs
Read More
Press Releases
|
Posted on 1.15.24
WhiteLab Genomics and Siren Biotechnology Announce Strategic Partnership to Accelerate AI-Powered Advancements in Gene Therapy
Read More
Media Coverage
|
Posted on 12.4.23
The comparability tales: A phase-appropriate roadmap for CGT drug product development
Read More
Media Coverage
|
Posted on 11.9.23
Webinar – Proactive Strategies for Biotech Success in the 2024 Landscape
Read More
Press Releases
|
Posted on 11.1.23
Siren Biotechnology Awarded $4M in Grant Funding from the California Institute for Regenerative Medicine (CIRM)
Read More
Media Coverage
|
Posted on 10.4.23
2023 All-In Summit – A discussion on the future of gene therapy
Read More
1
2
3
4
5
6
